Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on April 29, 2026

Apr. 29, 2026

VitalHub Announces Q1 2026 Conference Call Date

Indeterminate GlobeNewswire

Apr. 29, 2026

Denovo Announces Issuance of U.S. Patent of Novel Genetic Biomarker ANK3 (DGM4™) for Liafensine (DB104)

Indeterminate GlobeNewswire

Apr. 29, 2026

Ocular Therapeutix™ Announces First Patient Enrolled in SOL-X Long-Term Extension Trial for AXPAXLI™ in Wet AMD

Indeterminate GlobeNewswire

Apr. 29, 2026

Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at the 4th Annual Ticks and Tickborne Diseases Symposium…

Indeterminate GlobeNewswire

Apr. 29, 2026

Amarin Reports 2026 First Quarter Financial Results

Indeterminate GlobeNewswire

Apr. 29, 2026

Intellia Therapeutics Announces Pricing of Public Offering of Common Stock

Indeterminate GlobeNewswire

Apr. 29, 2026

Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives

Indeterminate GlobeNewswire

Apr. 29, 2026

Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy

Indeterminate GlobeNewswire

Apr. 29, 2026

Regeneron Reports First Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

Apr. 29, 2026

Agios Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Apr. 29, 2026

Boehringer Ingelheim and Eko Health Inc. launch new AI-based solution that detects heart murmurs in dogs

Indeterminate GlobeNewswire

Apr. 29, 2026

Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference

Indeterminate GlobeNewswire

Apr. 29, 2026

HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Indeterminate GlobeNewswire

Apr. 29, 2026

EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome

Indeterminate GlobeNewswire

Apr. 29, 2026

Enlitic Announces Full Integration with Sectra, Expanding Access for Sectra Customers

Indeterminate GlobeNewswire

Apr. 29, 2026

Angelini Ventures Invests in Hypervision Surgical’s £17 Million Series A to Advance Real-time Hyperspectral Imaging and Improve Clinical Outcomes in Surgery

Indeterminate GlobeNewswire

Apr. 29, 2026

Purespring announces publication of notable study highlighting an under recognised genetic driver of adult-onset FSGS, in particular in US and UK populations

Indeterminate GlobeNewswire

Apr. 29, 2026

Phonak Virto ™ R Infinio Earns 2026 Red Dot Award for Product Design

Indeterminate GlobeNewswire

Apr. 29, 2026

Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model

Indeterminate GlobeNewswire

Apr. 29, 2026

Dr. Björn Zoëga: O Dimensionamento de Sistemas Digitais Integrados Irá Definir o Futuro da Saúde

Indeterminate GlobeNewswire